Jakob Triebel Selected Research

Jakob Triebel Research Topics

Disease

9	Diabetic Retinopathy (Retinopathy, Diabetic) 09/2023 - 08/2009
7	Hyperprolactinemia 01/2022 - 10/2011
5	Cardiomyopathies (Cardiomyopathy) 01/2024 - 11/2016
4	Pre-Eclampsia (Preeclampsia) 01/2024 - 01/2017
2	Inflammation (Inflammations) 12/2023 - 09/2013
2	B-Cell Lymphoma (Lymphoma, B Cell) 11/2022 - 11/2019
2	Neoplasms (Cancer) 01/2022 - 11/2019
2	Osteoarthritis 01/2022 - 01/2018
2	Macular Edema 01/2018 - 01/2017
2	Retinopathy of Prematurity (Retrolental Fibroplasia) 01/2017 - 01/2017
2	Acute-Phase Reaction 10/2015 - 03/2012
2	Diabetes Mellitus 01/2015 - 10/2011
1	Non-alcoholic Fatty Liver Disease 05/2024
1	Pathologic Neovascularization 12/2023
1	Vitamin D Deficiency 11/2022
1	Retinal Neovascularization 01/2022
1	Retinal Detachment (Retinal Detachments) 01/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Prolactinoma (Prolactinomas) 01/2020
1	Lymphoma (Lymphomas) 11/2019
1	Disease Progression 01/2018
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Ischemia 01/2018
1	Atrial Fibrillation 01/2017
1	Birth Weight (Birth Weights) 01/2017
1	Sepsis (Septicemia) 01/2017
1	Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced) 01/2017
1	Rheumatoid Arthritis 01/2016
1	Heart Diseases (Heart Disease) 11/2015
1	Meningoencephalitis 01/2015
1	Infections 01/2015
1	Body Weight (Weight, Body) 10/2013
1	Arthritis (Polyarthritis) 09/2013
1	Pain (Aches) 09/2013
1	Blindness (Hysterical Blindness) 10/2011

Drug/Important Bio-Agent (IBA)

17	ProlactinIBA 05/2024 - 08/2009
8	Hormones (Hormone)IBA 12/2023 - 10/2011
7	Retinaldehyde (Retinal)IBA 01/2022 - 10/2011
5	levosulpirideIBA 09/2023 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 01/2024 - 10/2015
2	Rituximab (Mabthera)FDA Link 11/2022 - 11/2019
2	Placental Lactogen (Human Placental Lactogen)IBA 04/2022 - 01/2019
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 10/2013
2	Complement System Proteins (Complement)IBA 01/2022 - 01/2018
2	Interleukin-6 (Interleukin 6)IBA 10/2015 - 10/2013
2	CytokinesIBA 10/2013 - 09/2013
1	Vitamin D FDA LinkGeneric 11/2022
1	Cathepsin DIBA 01/2022
1	Sulpiride (neogama)IBA 01/2022
1	Dopamine D2 Receptor AntagonistsIBA 01/2022
1	Neoplasm Antigens (Tumor Antigens)IBA 11/2019
1	Monoclonal AntibodiesIBA 11/2019
1	daratumumabIBA 11/2019
1	Fc Receptors (Fc Receptor)IBA 11/2019
1	AntibodiesIBA 11/2019
1	Immunoglobulins (Immunoglobulin)IBA 11/2019
1	ElementsIBA 11/2019
1	obinutuzumabIBA 11/2019
1	EnzymesIBA 01/2019
1	Peptide Hormones (Polypeptide Hormones)IBA 01/2019
1	Ranibizumab (Lucentis)FDA Link 01/2018
1	Angiogenesis InhibitorsIBA 01/2018
1	Bromocriptine (Parlodel)FDA LinkGeneric 01/2017
1	AnticoagulantsIBA 01/2017
1	Dopamine (Intropin)FDA LinkGeneric 01/2017
1	Dopamine Agonists (Dopamine Agonist)IBA 11/2016
1	Biomarkers (Surrogate Marker)IBA 10/2015
1	Polysaccharides (Glycans)IBA 10/2015
1	C-Reactive ProteinIBA 10/2015
1	ProcalcitoninIBA 10/2015
1	endotoxin receptorIBA 10/2015
1	Lipopolysaccharide ReceptorsIBA 10/2015
1	Cholecalciferol (Vitamin D3)FDA Link 01/2015
1	Capsules (Microcapsules)IBA 10/2013
1	Insulin-Like Growth Factor I (IGF-1)IBA 07/2012
1	TurpentineIBA 03/2012
1	LigandsIBA 03/2012
1	Melanocortin Receptors (Melanocortin Receptor)IBA 03/2012
1	Pituitary HormonesIBA 10/2011

Therapy/Procedure

4	Therapeutics 12/2023 - 01/2017
2	Vitrectomy 01/2020 - 01/2018
1	Oral Administration 01/2022
1	Immunotherapy 11/2019
1	Contraindications 01/2017